Journal Mobile Options
Table of Contents
Vol. 7, No. 3, 2001
Issue release date: August 2001
Section title: Paper
Eur Addict Res 2001;7:138–147
(DOI:10.1159/000050731)

Steps towards Constructing a Global Comparative Risk Analysis for Alcohol Consumption: Determining Indicators and Empirical Weights for Patterns of Drinking, Deciding about Theoretical Minimum, and Dealing with Different Consequences

Rehm J.a-c · Monteiro M.d · Room R.e · Gmel G.f · Jernigan D.g · Frick U.h · Graham K.b
aAddiction Research Institute, Zürich, Switzerland; bCentre for Addiction and Mental Health, Toronto, Ont.; cUniversity of Toronto, Ont., Canada; dWorld Health Organization, Geneva, Switzerland; eCentre for Social Research on Alcohol and Drugs, Stockholm University, Stockholm, Sweden; fSwiss Institute for the Prevention of Alcohol and Other Drug Problems, Lausanne, Switzerland; gMarin Institute for the Prevention of Alcohol and Other Drug Problems, San Rafael, Calif., USA, and hUniversity of Regensburg, Germany

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 8/8/2001
Issue release date: August 2001

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 4

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: http://www.karger.com/EAR

Abstract

In order to conduct a comparative risk analysis for alcohol within the Global Burden of Disease Study (GBD 2000), several questions had to be answered. (1) What are the appropriate dimensions for alcohol consumption and how can they be categorized? The average volume of alcohol and patterns of drinking were selected as dimensions. Both dimensions could be looked upon as continuous but were categorized for practical purposes. The average volume of drinking was categorized into the following categories: abstention; drinking 1 (>0–19.99 g pure alcohol daily for females, >0–39.99 g for males); drinking 2 (20–39.99 g for females, 40–59.99 g for males), and drinking 3 (≧40 g for females, ≧60 g for males). Patterns of drinking were categorized into four levels of detrimental impact based on an optimal scaling analysis of key informant ratings. (2) What is the theoretical minimum for both dimensions? A pattern of regular light drinking (at most 1 drink every day) was selected as theoretical minimum for established market economies for all people above age 45. For all other regions and age groups, the theoretical minimum was set to zero. Potential problems and uncertainties with this selection are discussed. (3) What are the health outcomes for alcohol and how do they relate to the dimensions? Overall, more than 60 disease conditions were identified as being related to alcohol consumption. Most chronic conditions seem to be related to volume only (exceptions are coronary heart disease and ischemic stroke), and most acute conditions seem to be related to volume and patterns. In addition, using methodology based on aggregate data, patterns were relevant for attributing harms for men but not women.

© 2001 S. Karger AG, Basel


  

Author Contacts

Prof. Dr. Jürgen Rehm
Addiction Research Institute
Konradstrasse 32, PO Box
CH–8031 Zürich (Switzerland)
E-Mail jtrehm@isf.unizh.ch or jtrehm@aol.com

  

Article Information

Number of Print Pages : 10
Number of Figures : 1, Number of Tables : 4, Number of References : 35

  

Publication Details

European Addiction Research (Special Topic Section: Craving and Anticraving)

Vol. 7, No. 3, Year 2001 (Cover Date: August 2001)

Journal Editor: M. Krausz, Hamburg; A. Uchtenhagen, Zurich
ISSN: 1022–6877 (print), 1421–9891 (Online)

For additional information: http://www.karger.com/journals/ear


Article / Publication Details

First-Page Preview
Abstract of Paper

Published online: 8/8/2001
Issue release date: August 2001

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 4

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: http://www.karger.com/EAR


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.